Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorderRecruitingPhase 32026-10-07NCT06716021

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Milestone Pharmaceuticals Inc.2

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Bravis ziekenhuisRoosendaalNetherlands1
Cardiovascular Associates Of The Delaware ValleyHaddon HeightsUnited States6
Elkerliek ZiekenhuisHelmondNetherlands2
Frisius Medisch CentrumFrieslandNetherlands1
Gelre ZiekenhuizenApeldoornNetherlands3
Ikazia ZiekenhuisRotterdamNetherlands1
Interventional Cardiology Medical Group (West Hills, CA)West HillsUnited States1
Jeroen Bosch Ziekenhuis's-HertogenboschNetherlands6
Montreal Heart InstituteMontrealCanada9
Noordwest ZiekenhuisgroepAlkmaarNetherlands3
Rijnstate ZiekenhuisArnhemNetherlands1
South Denver Cardiology Associates P.CLittletonUnited States1
Van Weel-Bethesda ZiekenhuisDirkslandNetherlands1
Weill Cornell MedicineManhattanUnited States2
ZGTAlmeloNetherlands1